Research
Hormonal
High consumption of sugar-sweetened beverages and high-glycemic load carbohydrates increases the risk of weight gain and type 2 diabetes, particularly in individuals with higher BMI or insulin resistance.
Limit sugar-sweetened beverages and foods with a high glycemic load, especially if you have a higher BMI or insulin resistance. Focus on whole grains and high-fiber carbohydrates instead, as these are associated with lower risks of weight gain and type 2 diabetes.
GoodSupportsHIGH confidence
One form of carbohydrate intake that is devoid of fibre and has a high glycaemic load is sugar-sweetened soda beverages... We have recently reported that high soda consumption is related to both weight gain and type 2 diabetes... the adverse effects of high glycaemic load... is influenced by the underlying degree of insulin resistance.
Why this rating
Supported by prospective cohort studies and randomized trials, though the paper notes that direct measurement of insulin resistance is difficult and BMI is used as a surrogate.
Source
The Mediterranean diet: science and practice
Walter C. Willett · Public Health Nutrition · 2006
DOI 10.1079/phn2005931
narrative_reviewCited 344×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Replacing saturated and trans fats with monounsaturated and polyunsaturated fats significantly reduces the risk of coronary heart disease by improving lipid profiles (lowering LDL, raising HDL, lowering triglycerides) and reducing inflammation and thrombotic tendency.Strong
- Adherence to a traditional Mediterranean dietary pattern, combined with not smoking, maintaining a healthy BMI, and regular physical activity, can prevent over 80% of coronary heart disease, 70% of stroke, and 90% of type 2 diabetes.Strong
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →